Back to Journals » Drug Design, Development and Therapy » Volume 10 » Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
Please verify you are not a robot.